Could a gel replace a chemo drug in eye surgery?
NCT ID NCT07504250
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two treatments used during tear duct surgery for blocked tear ducts: hyaluronic acid gel versus the chemotherapy drug mitomycin-C. The goal is to see if the gel works as well or better at keeping the new tear duct open, with fewer side effects. Thirty-six adults with chronic dacryocystitis will be randomly assigned to one of the two treatments, and their surgical success, complications, and comfort will be tracked for six weeks after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- hyaluronic acid (gel) and mitomycin-C (drug)
- What this could lead to
- If hyaluronic acid works as well as mitomycin-C, it could offer a safer option during tear duct surgery with fewer side effects.
- What could go wrong
- This is a small, early-phase trial with only 36 participants, so results may not apply widely. Hyaluronic acid might not be as effective as the standard treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC DACRYOCYSTITIS DUE TO PRIMARY ACQUIRED NASOLACRIMAL DUCT OBSTRUCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.